Strengthening the Safety and Resilience of the Infant Formula Supply

A Renewed Commitment to Infant Nutrition

Under the leadership of HHS Secretary Robert F. Kennedy, Jr., the FDA is taking decisive action to bolster the quality, safety, and availability of infant formula in the United States. This renewed focus prioritizes the nutritional needs of our nation's most vulnerable population – our infants and young children.

“The FDA will use all resources and authorities at its disposal to make sure infant formula products are safe and wholesome for the families and children who rely on them,” stated Secretary Kennedy. “Helping each family and child get off to the right start from birth is critical to our pursuit to Make America Healthy Again.”

Enhanced FDA Initiatives for Infant Formula

The FDA is implementing a multi-pronged approach to ensure a robust and reliable infant formula supply. This includes a comprehensive review of infant formula nutrients – the first since 1998 – and increased testing for heavy metals and other contaminants. The agency is also promoting the development of new formulas and working towards clearer labeling to better inform consumers.

“The FDA is deeply committed to ensuring that parents and caregivers have full confidence in the safety and availability of infant formula,” explained Acting FDA Commissioner Sara Brenner, M.D., M.P.H. “Whether breastfed, bottle-fed, or both, ensuring proper nourishment for the rising generation is paramount for their lifelong health and well-being.”

This commitment translates into concrete actions, including extending the personal importation policy and collaborating with scientific bodies like the National Institutes of Health to address critical research gaps concerning the long-term health outcomes of formula feeding.

Key Actions the FDA is Taking

The FDA is leveraging its authority to uphold the highest standards for infant formula. Key initiatives include:

• Initiating a comprehensive nutrient review.
• Increasing testing for heavy metals and other contaminants.
• Extending the personal importation policy.
• Encouraging greater transparency in labeling and ingredient information.
• Maintaining open communication with consumers and industry stakeholders.
• Collaborating with scientific institutions to address research gaps.

A Focus on Continuous Improvement

The FDA remains steadfast in its dedication to ensuring that the U.S. infant formula supply is the safest and most reliable in the world. These ongoing efforts underscore the agency's commitment to the health and well-being of infants and young children.